Diabetes Accessories
- A1c kits
- Adhesives/Creams
- Awareness Products
- Bags
- Books
- Clothing
- Diabetes Socks
- Emergency Kits
- Glucose Tablets/Drinks
- Injection Aids
- Insulin Coolers
- Jewelry
- Ketostix
- Log Books
- Magnifying Aids
- Meter Cases
- Nutritional Scales
- Other
- Pill Boxes
- Portable Fridges
- Portion Control Containers
- Pump Packs/Pouches
- Sharps Containers
- Syringe Holders
- Water proof pump cases
- Waterproof Insulin Pump Cases
General Diabetes Information
- Advocacy
- Associations
- Continuous Glucose Monitor Companies
- Dictionaries
- Emergency Information
- Home Delivery Services
- Insulin Pump Companies
- Insurance
- Organizations
- Pharmaceutical Companies
- Traveling
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- DC
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Lousiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Puerto Rico
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virgin Islands
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
fda (17)
-
Label, label on the Box
I am a creature of habit. The recent news of change to the beloved food label is unsettling to me. Word is the FDA is applying a face-lift to nutrition panel. As a person with diabetes who counts on carbs to dose insulin, it’s imperative that carbohydrates be included in the updated food labels. For good measure, I hope […]
more... -
Minimed 530G with Enlite
It’s a bird. It’s a plane. It’s the Minimed 530G with Enlite. It’s the fanciest, most advanced glucose regulated insulin pump available today. Thanks to FDA clearance, all of us who wear an insulin pump and a continuous glucose monitor are a step closer to the artificial pancreas. Until the day when the software exists […]
more... -
New T2D Drug: Blockbuster or Bridge to Nowhere
A new Type 2 diabetes drug is under development by Johnson & Johnson (JNJ) and if approved will be marketed as Invokana. The drug works by excreting glucose into the urine. This puts a high demand of labor on the kidneys and the FDA advisory panel expressed concerns about the risk of harm to the […]
more... -
Riva Greenberg’s 10 Diabetes Advances in 2012
Riva Greenberg needs no introduction to those who seek to live an exceptional life, not despite diabetes but because of it. If you have yet to reach the summit of diabetes enlightenment, allow me to introduce Riva Greenberg. She is an author, a speaker, and a person living with Type 1 diabetes for 40 years. […]
more... -
Good Tidings for C-peptide Replacement Trial
It has been an object of my desire since I first learned about c-peptide in 2007. A study has demonstrated that C-peptide replacement therapy protects against complications of T1D. One of the researchers championing c-peptide is Dr. John Wahren. He is the Chief Scientific Officer and a board member of Cebix, the company serving the […]
more... -
The Relationship between Eye and Kidney Blood flow in Type 2 Diabetes
Researchers wanted to study the relationship between retinal blood flow and kidney function in patients with Type 2 diabetes. The kidney blood flow is essential to filter the blood. The retinal blood flow is essential to maintain vision. Lack of blood to either organ means lack of oxygen throughout the body. Most living things need oxygen to […]
more... -
Antidepressant to Protect against Diabetes Vascular Complications
Researchers at the University of Texas Medical Branch at Galveston discovered that the commonly used antidepressant drug Paxil could also become a therapy for the vascular complications of diabetes. Vascular complications are responsible for most of the complications due to diabetes. Blood vessels, large and small, are abnormal in diabetic patients with long standing disease. […]
more... -
Russian Roulette in the Insulin Analogue Game
The Diabetes Technology & Therapeutics article asks the question is the emergence of biosimilar insulin a cause for concern? To know a little about the history of two royal subjects about to be dethroned, NovoLog and Levemir, we need to understand that the manufacturing process for analogues is still “patent pending”. With this in mind, […]
more... -
Matthew McConaughey in an Exercise of Discipline
Never in my wildest dreams did I think I could justify a picture of Matthew McConaughey on The Diabetes Resource. I must be dreaming. Matthew McConaughey fears he could provoke diabetes when his work comes to an end on the movie Dallas Buyers Club. The interview with Larry King explains the plot of the movie and why McConaughey is looking […]
more... -
‘Foolish’ Five Companies to Dominate in Diabetes
According to the Motley Fool, a financial-services company with the sole purpose to help the world invest (better), 8% of the U.S. population is affected by diabetes. The top companies poised to profit from this experience are: Novo Nordisk (NYSE: NVO), Snofi (NYSC: SNY), MannKind (Nasdaq: MNKD), Bristol-Myers Squibb (NYSE: BMY), and AstraZeneca (NYSE: AZN). […]
more...
Bloggers
Media